Cologne University Hospital, Prof. Dr Michael Hallek: a get-together between researchers and external funding bodies

Tumour microenvironment, CAR-T cells, dendritic cell platforms: oncology is experiencing a phase of scientific breakthroughs that have the potential to fundamentally transform the treatment of cancer. Modern research approaches shed light on how tumour cells interact with their environment – from the metabolic reprogramming of immune cells to the role of neural structures in tumour development. At the same time, new immunotherapies are revolutionising clinical practice and creating therapeutic possibilities where previously there were hardly any options. The aim of this translational research is to translate fundamental scientific findings directly into better diagnostic and treatment strategies for patients.

In the year marking its 50th anniversary, the Wilhelm Sander Foundation is organising a scientific symposium in collaboration with the University Hospital of Cologne. The University Hospital of Cologne ranks among the most important centres for oncological research in Germany – a long-standing and fruitful partnership that we are further strengthening with this symposium.

As part of this event, leading experts from Cologne, Bonn, London and Lausanne will present current research projects in the fields of the tumour microenvironment, immunotherapy and AI-supported cancer diagnostics. The symposium offers an opportunity to further deepen the intensive exchange of ideas between cutting-edge international research and clinical practice in Cologne.